GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Other Stockholders Equity

Biomics Biopharma (ASX:BBM) Other Stockholders Equity : A$0.00 Mil (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Other Stockholders Equity?

Biomics Biopharma's Other Stockholders Equity for the quarter that ended in . 20 was A$0.00 Mil.


Biomics Biopharma Other Stockholders Equity Historical Data

The historical data trend for Biomics Biopharma's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Other Stockholders Equity Chart

Biomics Biopharma Annual Data
Trend
Other Stockholders Equity

Biomics Biopharma Semi-Annual Data
Other Stockholders Equity

Biomics Biopharma Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Biomics Biopharma Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines